Antibiotic resistance - What we have to do now?;Antybiotykooporność - Co musimy zrobić dziś?

Polski Merkuriusz Lekarski

Volumn 30, Issue 179, 2011, Pages 305-309

  Hryniewicz, W ^a  

^a Zakład Epidemiologii I Mikrobiologii Klinicznej   (Poland)

Author keywords

Antibiotic resistance; Microbiological diagnostics; Rational therapy

Indexed keywords

ANTIINFECTIVE AGENT;

ANIMAL; ANTIBIOTIC RESISTANCE; COMMUNICABLE DISEASE; DRUG CONTROL; DRUG UTILIZATION; FORECASTING; HUMAN; MANAGEMENT; METHODOLOGY; REVIEW;

ANIMALS; ANTI-BACTERIAL AGENTS; COMMUNICABLE DISEASES; DRUG AND NARCOTIC CONTROL; DRUG RESISTANCE, MICROBIAL; DRUG UTILIZATION; FORECASTING; HUMANS; POLICY MAKING;

EID: 79959423572     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Allerberger F., Gareis R., Indrak V. et al.: Antibiotic stewardship implementation in the EU: the way forward. Expert Rev. Anti-lnfect. Ther., 2009;7:1175-1183.
2. Baraniak A., Izdebski R., Herda M. et al.: Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland. Antimicrob. Agents Chemother., 2009;53:4565-4567.
3. Bartlett J., Boucher H. W., Bradley J. S.: Sad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America. Clin. Infect. Dis., 2009;48:1-12.
4. Bronzwaer S. L, Cars O., Buchholz U. et al.: A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg. Infect. Dis., 2002;8:278-82 (Pubitemid 34266265)
5. David M. Z., Daum R. S.: Community-Associated Methicillin-Resistant Staphylococcus aureus:epidemiology and clinical consequences of an emerging epidemic. Clin. Microbiol. Rev., 2010;23:616-687.
6. Dellit T. H., Owens R. C. McGowan J. E. et al.: Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin. Infect. Dis., 2007;44:159-177. (Pubitemid 46084814)
7. Empel J., Baraniak A., Literacka E. et al.: Molecular survey of ß-lactamases confening resistance to newer β-lactams in Enterobacteriaceae isolates from Polish hospitals. Antimicrob. Agents Chemother., 2008;52:2449-2454. (Pubitemid 351923073)
8. Freire-Morau L, Aronsson B., Manz C. et al.: Critical shortage of new antibiotics in development against multidrug-resistant bacteria - Time to react is now. Drug Resist. Update, 2011; March (Epub ahead of print)
9. Hryniewicz W.: Zasady leczenia przeciwdrobnoustrojowego, (w) Choroby wewnȩtrzne: stan wiedzy na rok 2011. Szczeklik A., (red.), Medycyna Praktyczna, Krakow, 2011:2115-2134
10. Gniadkowski M.: Evolution of extended spectrum beta-lactamases by mutation. Clin. Microbiol. Infect., 2008; suppl 1:11-32. (Pubitemid 350284180)
11. Kawalec M., Kedzierska J., Gajda A. et al.: Hospital outbreak of vancomycin-resistant enterococci caused by a single clone of Enterococcus raffinosus and several clones of Enterococcus faecium. Clin. Microbiol. Infect., 2007;13:893-901. (Pubitemid 47244139)
12. Kock R., Becker K., Cookson B. et al.: Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill, 2010;15:pii19688.
13. Kumarasamy K. K., Toleman MA., Walsh T. R. et al.: Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect. Dis., 2010;10:597-602.
14. Łuczak-Kadłubowska A., Sulikowska A., Empel J. et al.: Countrywide molecular survey of methicillin-resistant Staphylococcus aureus strains in Poland. J. Clin. Microbiol., 2008;46:2930-2937.
15. Mouton J. W., Ambrose P. G., Canton R. et al.: Conserving antibiotics for the future: New ways to use old and new drugs from pharmacokinetic and pharmacodynamic perspective. Drug Resistance Update. 2011; Mar. 25. (Epub ahead of print).
16. Munoz-Price L. S., Quinn J. P.: The spread of Klebsiella pneumoniae carbapenemases:a tale of strains, plasmids, and transposons. Clin. Infect. Dis., 2009;49:1739-41.
17. Neonakis I. K., Samonis G., Messaritakis H.: Resistance status and evolution trends of Klebsiella pneumoniae isolates in a university hospital in Greece: in effectiveness of carbapenems and increasing resistance to colistin. Chemother, 2010;56:448-452.
18. Patzer J. A., Walsh T. R., Weeks J. et al.: Emergence and persistence of integron structures harbouring VIM genes in the Children's Memorial Health Institute, Warsaw, Poland. 1998-2006. J Antimicrob. Chemother, 2009;63:269-73.
19. Rodriguez-Martinez J. M., Nordmann P., Ronco E. et al.: Extended-spectrum cephalosporinase in Acinetobacter baumanni. Antimicrob. Agents Chemother., 2010;54:3484-8.
20. Skoczynska A., Sadowy E., Bojarska K. et al.: The current status of invasive pneumococcal disease in Poland. Vaccine, 2011;29:2199-205.
21. Walsh T. R.: Emerging carbapenemases: a global perspective. Int. J. Antimicrob. Agents, 2010;36/suppl. 3:S8-14.
22. The bacterial challenge: time to ReAct. ReAct/ECDC/EMEA joint technical report. European Centre for Disease Prevention and Control, 2009.
23. Van Cleeef B. A., Monnet D., Voss A. et al.: Livestock-associated Methicillin-Resistant Staphylococcus aureus in humans in Europe. Emerg. Infect. Dis., 2011;17:502-505.
24. Wegener H. C.: Antibiotics in animal feed and their role in resistance development. Curr. Opin. Microbiol., 2003;6:439-45. (Pubitemid 37345407)